Oral medications in nasal decongestion. A study among industrial workers.
D001977:Brompheniramine / Q000008:administration & dosage; D002744:Chlorpheniramine / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D003692:Delayed-Action Preparations; D004809:Ephedrine / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008297:Male; D014663:Nasal Decongestants / Q000008:administration & dosage*; D009784:Occupational Diseases / Q000188:drug therapy*; D010276:Parasympatholytics / Q000008:administration & dosage; D010665:Phenylpropanolamine / Q000008:administration & dosage; D012130:Respiratory Hypersensitivity / Q000188:drug therapy*; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy; D013566:Sympathomimetics / Q000008:administration & dosage; D014311:Triprolidine / Q000008:administration & dosage; D014662:Vasoconstrictor Agents / Q000008:administration & dosage*
D003692:Delayed-Action Preparations; D014663:Nasal Decongestants; D010276:Parasympatholytics; D013566:Sympathomimetics; D014662:Vasoconstrictor Agents; D014311:Triprolidine; D010665:Phenylpropanolamine; D002744:Chlorpheniramine; D004809:Ephedrine; D001977:Brompheniramine